NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030220019

Registered date:13/04/2022

Symptom burden study

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedASTHMA
Date of first enrollment06/05/2022
Target sample size400
Countries of recruitment
Study typeObservational
Intervention(s)none

Outcome(s)

Primary OutcomeHealth-related quality of life measured by AHQ-33 scores in all participants, the WC and NWC participant subgroups
Secondary Outcome1)Distribution of Work Productivity and Activity Impairment:Asthma (WPAI:Asthma) scores in all participants, and the WC and NWC participant subgroups 2)Distribution of Leicester Cough Questionnaire (LCQ) scores in all participants, and the WC and NWC participant subgroups 3)Distribution of Description of the patient characteristics in all participants and by WC and NWC participant subgroups

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteria1)Men and women aged >-20 years 2)Patients who have been diagnosed with asthma 3)Patients using ICS/LABA combination therapy for >-4 weeks 4)Patients with moderate or high MMAS status 5)Patients who are able to answer the questions through the website
Exclude criteria1)Patients using a biologic asthma medication 2)Patients who have been diagnosed with chronic obstructive pulmonary disease 3)Patients using long-acting muscarinic antagonist medication 4)Patients with a smoking history of >-10 years

Related Information

Contact

Public contact
Name Takeo Ishii
Address Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, Japan Tokyo Japan 107-0052
Telephone +81-120-561-007
E-mail jp.gskjrct@gsk.com
Affiliation GlaxoSmithKline K.K.
Scientific contact
Name Takeo Ishii
Address Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, Japan Tokyo Japan 107-0052
Telephone +81-120-561-007
E-mail jp.gskjrct@gsk.com
Affiliation GlaxoSmithKline K.K.